Is it Wise to Prescribe NSAIDs with Modern Gastroprotective Agents?

References

• Shea-Donohue T, Steel L, Montcalm E, Dubois A. Gastric protection by sucralfate: role of mucus and prostaglandins. Gastroenterology 1986; 91: 660–6
   PubMed Web of Science ®Google Scholar
• Rainsford KD. The effects of aspirin and other non-steroidal anti-inflammatory/analgesic drugs on gastrointestinal mucus glycoprotein biosynthesis in vivo: relationship to ulcerogenic actions. Biochem Pharmacol 1978; 27: 877–85
   PubMed Web of Science ®Google Scholar
• Ishihara K, Ohara S, Azuumi Y, Goso K, Hotta K. Changes of gastric mucus glycoproteins with aspirin administration in rats. Digestion 1984; 29: 98–102
   PubMed Web of Science ®Google Scholar
• Dekanski J B., Mac Donald A, Sacra P, Parke DV. Effects of fasting, stress and drugs on gastric glycoprotein synthesis in the rat. Br J Pharmac 1975; 55: 387–92
   PubMed Web of Science ®Google Scholar
• Menguy R, Masters YF. Effects of aspirin on gastric mucous secretion. Surg Gynecol Obstet 1965; 120: 92–8
   PubMedGoogle Scholar
• Sarosiek J, Slomiany B L., Swierczek J, Slomiany A, Jozwiakz Z, Konturek SJ. Effect of acetylsalicylic acid on the constituents of the gastric mucosal barrier. Scand J Gastroenterol 1984; 19: 150–3
   PubMed Web of Science ®Google Scholar
• Oketani K, Murakami M, Fujisaki H, Wakabayashi T. Effect of geranylgeranylacetone on aspirin-induced changes in gastric glycoproteins. Japan J Pharmacol 1983; 33: 593–601
   PubMedGoogle Scholar
• Kent P, Allen A. The biosynthesis of intestinal mucins. Biochem J 1968; 106: 654–58
   Web of Science ®Google Scholar
• Hills B A., Butler B D., Lichtenberger LM. Gastric mucosal barrier: hydrophobic lining to the lumen of the stomach. Am J Physiol 1983; 244: G561–8
   Google Scholar
• Goddard P J., Hills B A., Lichtenberger LM. Does aspirin (ASA) damage the stomach by decreasing gastric mucosal surface hydrophobicity?. Gastroenterology 1985; 88: 1714, abstract
   Web of Science ®Google Scholar
• Cheung L Y., De L, Ashley SW. Effect of aspirin on epithelial cell membrane potentials of gastric fundic mucosa. Surgery 1984; 96: 171–8
   PubMed Web of Science ®Google Scholar
• Cheung L Y., De L, Ashley SW. Intracellular microelectrode studies of necturus antral mucosa. Gastroenterology 1985; 88: 261–8
   PubMed Web of Science ®Google Scholar
• Ross I N., Bahari H MM, Turnberg LA. The pH gradient across mucus adherent to rat fundic mucosa in vivo and the effect of potential damaging agents. Gastroenterology 1981; 81: 713–8
   PubMed Web of Science ®Google Scholar
• Garner A. Effects of acetylsalicylate on alkalinization, acid secretion and electrogenic properties in the isolated gastric mucosa. Acta Physiol Scand 1977; 99: 281–91
   PubMedGoogle Scholar
• Garner A. Mechanisms of action of aspirin on the gastric mucosa of the guinea pig. Acta Physiol Scand 1978; 101–10, Special Suppl.
   PubMedGoogle Scholar
• Rees W D., Warhurst G, Turnberg LA. Studies of bicarbonate secretion by the normal human stomach in vivo: effect of sodium taurocholate and aspirin. Gastroenterology 1982; 82: 1158, abstract
   Web of Science ®Google Scholar
• Rees W D., Gibbons L C., Turnberg LA. Alkali secretion by isolated rabbit gastric mucosa: effects of non-steroidal anti-inflammatory drugs and prostaglandins. Scand J Gastroenterol 1984; 19: 63–8, suppl. 92
   Web of Science ®Google Scholar
• Takeuchi K, Ueki S, Tanaka H. Endogenous prostaglandins in gastric alkaline response in the rat stomach after damage. Am J Physiol 1986; 250: G842–9
   Google Scholar
• Rowe P H., Lange R, Marrone G, Matthews J B., Kasdon E, Silen W. In vitro protection of amphibian gastric mucosa by nutrient HCO3 against aspirin injury. Gastroenterology 1985; 89: 767–78
   PubMed Web of Science ®Google Scholar
• Bugart R, Thompson M R., Aures D, Grossman MI. Gastric mucosal lesions produced by intravenous infusion of aspirin in cats. Gastroenterology 1976; 71: 754–9
   PubMed Web of Science ®Google Scholar
• Davenport HW. Gastric mucosal hemorrhage in dogs. Effects of acid, aspirin, and alcohol. Gastroenterology 1969; 56: 439–49
   PubMed Web of Science ®Google Scholar
• Bruggeman T M., Wood J G., Davenport HW. Local control of blood flow in the dog's stomach: vasodilatation caused by acid back-diffusion following topical application of salicylic acid. Gastroenterology 1979; 77: 736–44
   PubMed Web of Science ®Google Scholar
• Kauffman GL, Jr, Aures D, Grossman MI. Intravenous indomethacin and aspirin reduce basal gastric mucosal blood flow in dogs. Am J Physiol 1980; 23: G131–4
   Google Scholar
• Kitahora T, Guth PH. Effect of aspirin on the rat gastric microcirculation. Gastroenterology 1986; 80: 1494, abstract
   Google Scholar
• Cheung L Y., Moody F G., Reese RS. Effect of aspirin, bile salt and ethanol on canine gastric mucosal blood flow. Surgery 1975; 77: 786–92
   PubMed Web of Science ®Google Scholar
• Rainsford KD. A profile of gastric ulcerogenic activity of benoxaprofen compared with other nonsteroidal anti-inflammatory drugs in rats, stressed or given alcohol, and in pigs. Eur J Rheumatol 1982; 5: 148–64
   PubMed Web of Science ®Google Scholar
• Domschke S, Domschke W. Gastroduodenal damage due to drugs, alcohol and smoking. Clin Gastroenterol 1984; 13: 405–36
   PubMedGoogle Scholar
• Silvoso G R., Ivey K J., Butt J H., et al. Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy. Ann Intern Med 1979; 91: 517–20
   PubMed Web of Science ®Google Scholar
• Lockard O O., Ivey K J., Butt J H., Silvoso G R., Sisk C, Holt S. The prevalence of duodenal lesions in patients with rheumatic diseases on chronic aspirin therapy. Gastrointes Endosc 1980; 26: 5
   PubMed Web of Science ®Google Scholar
• Cooke A L., Goulston K. Failure of intravenous aspirin to increase gastrointestinal blood loss. Br Med J 1969; 3: 330–2
   PubMed Web of Science ®Google Scholar
• Leonards J R., Levy G. Reduction or prevention of aspirin-induced occult gastrointestinal blood loss in man. Clin Pharmacol Ther 1969; 10: 571–5
   PubMed Web of Science ®Google Scholar
• Leonards J R., Levy G. Aspirin-induced occult gastrointestinal blood loss: local versus systemic effects. J Pharm Sci 1970; 59: 1511–3
   PubMed Web of Science ®Google Scholar
• Grossman M I., Matsumoto K K., Lichter RJ. Fecal blood loss produced by oral and intravenous administration of various salicylates. Gastroenterology 1961; 40: 383–8
   PubMed Web of Science ®Google Scholar
• Brodie D A., Chase BJ. Role of gastric acid in aspirin-induced gastric irritation in the rat. Gastroenterology 1967; 53: 604–10
   PubMed Web of Science ®Google Scholar
• Graham D Y., Smith J L., Dobbs SM. Gastric adaptation occurs with aspirin administration in man. Dig Dis Sci 1983; 28: 1–6
   PubMed Web of Science ®Google Scholar
• Leonards J R., Levy G, Niemczura R. Gastrointestinal blood loss during prolonged aspirin administration. N Engl J Med 1973; 289: 1020–2
   PubMed Web of Science ®Google Scholar
• O'Laughlin J C., Hoftiezer J W., Ivey KJ. Effect of aspirin on the human stomach in normals: endoscopic comparison of damage produced one hour, 24 hours, and 2 weeks after administration. Scand J Gastroenterol 1981; 16: 211–4, suppl. 67
   Web of Science ®Google Scholar
• Peskar BM. On the synthesis of prostaglandins by human gastric mucosa and its modification by drugs. Biochem Biophys Acta 1977; 487: 307–14
   PubMed Web of Science ®Google Scholar
• Peskar BM. Das Prostaglandin-und Thromboxansystem des Magenschleimhaut als Angriffspunkt protektiver und ulzerogcnener. Pharmakr Wien Klin Wochenschr 1984; 96(4)133–8, 17
   PubMedGoogle Scholar
• Rachmilewitz D, Ligumsky M, Fich A, Goldin E, Eliakim A, Karmely F. Role of endogenous gastric prostanoids in the pathogenesis and therapy of duodenal ulcer. Gastroenterology 1986; 90: 963–9
   PubMed Web of Science ®Google Scholar
• Rachmilewitz D, Polak D, Eliakim R, et al. Cimetidine significantly decreases indomethacin induced gastroduodenal mucosal damage. Gastroenterology 1986; 90: 1596, abstract
   Web of Science ®Google Scholar
• Kobayashi K, Arakawa T, Satoh H, Fukuda T, Nakamura H. Effect of indomethacin, tiaprofenic acid and diclofenac on rat gastric mucosal damage and content of prostacyclin and prostaglandin E2. Prostaglandins 1985; 30: 609, abstract
   PubMedGoogle Scholar
• Whittle B JR. Temporal relationship between cyclo-oxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology 1981; 80: 94–8
   PubMed Web of Science ®Google Scholar
• Ligumsky M, Golansky E M., Hansen D G., Kauffman GL. Aspirin can inhibit gastric mucosal cyclooxygenase without causing lesions in rat. Gastroenterology 1983; 84: 756–61
   PubMed Web of Science ®Google Scholar
• Konturek S J., Kwiecien N, Obtulowicz W, Polanski M, Kopp B, Oleksy J. Comparison of prostaglandin E2 and ranitidine in prevention of gastric bleeding by aspirin in man. Gut 1983; 24: 89–93
   PubMed Web of Science ®Google Scholar
• Konturek S J., Kwiecien N, Obtulowicz W, et al. The use of carprofen, a non-steroidal anti-inflammatory agent, in peptic ulcer diseases. Hepatogastroenterol 1983; 30: 261–5
   PubMedGoogle Scholar
• Konturek S J., Kwiecien N, Obtulowicz W, Oleksy J, Sito E, Kopp B. Prostaglandins in peptic ulcer disease: effect of non-steroidal anti-inflammatory compounds (NOSAC). Scand J Gastroenterol 1984; 19: 250–4, suppl. 92
   Web of Science ®Google Scholar
• Konturek S J., Obtulowicz W, Kwiecien N, Oleksy J. Generation of prostaglandins in gastric mucosa of patients with peptic ulcer disease: effect of non-steroidal anti-inflammatory compounds. Scand J Gastroenterol 1984; 19: 75–7, suppl. 101
   Web of Science ®Google Scholar
• Levine B A., Petokas S, Nandi J, Enthoven D. Role of gastric acid in gastrointestinal injury by nonsteroidal, anti-inflammatory drugs (NSAIDs). Gastroenterology 1986; 90: 1520, abstract
   Web of Science ®Google Scholar
• Del Soldato P, Foschi D, Benoni G, Scarpignato C. Oxygen free radicals interact with indomethacin to cause gastrointestinal injury. Agents Actions 1985; 17: 484–8
   Google Scholar
• Smeaton L A., Hirst B H., Allen A, Garner A. Gastric and duodenal HCO3− transport in vivo: influence of prostaglandins. Am J Physiol 1983; 245: G751–9
   Google Scholar
• Gerkens J F., Shand D G., Flexner C, Nies A S., Oates J A., Data JL. Effect of indomethacin and aspirin on gastric blood flow and acid secretion. J Phar Exp Ther 1977; 203: 646–52
   PubMed Web of Science ®Google Scholar
• Slomiany B L., Kosmala M, Carter S R., Slomiany A, Konturek SJ. Intestinal release of mucin and HCO3− in response to luminal HCl and taurocholate: effect of indomethacin. Gastroenterology 1986; 90: 1638, abstract
   Web of Science ®Google Scholar
• Selling J A., Hogan D L., Koss M A., Isenberg JI. Human proximal versus distal duodenal bicarbonate secretion: effect of endogenous prostaglandin synthesis. Gastroenterology 1985; 88: 1580, abstract
   Web of Science ®Google Scholar
• Garner A, Flemström G, Heylings JR. Effects of antiinflammatory agents and prostaglandins on acid and bicarbonate secretions in the amphibian isolated gastric mucosa. Gastroenterology 1979; 77: 451–7
   PubMed Web of Science ®Google Scholar
• Whittle B JR. Mechanisms underlying gastric mucosal damage induced by indomethacin and bile-salts, and the actions of prostaglandins. Br J Pharmacol 1977; 60: 455–60
   PubMed Web of Science ®Google Scholar
• Baumgartner A, Koelz H R., Robert Y, Halter F. Hat die trophische Wirkung von Prostaglandinen auf die Magenschleimhaut eine physiologische Bedcutung? Schweiz Med Wochenschr 1985; 115: 1031
   Google Scholar
• Baumgartner A, Koelz H R., Halter F. Indomethacin and turnover of gastric mucosal cells in the rat. Am J Physiol 1986; 250: G830–5
   PubMed Web of Science ®Google Scholar
• Hirose F, Mizui T, Shimono N, Doteuchi M. Gastric antral ulcers induced by a combination of acid, indomethacin and ischemia in rats. Japan J Pharmacol 1985; 38: 223–6
   PubMedGoogle Scholar
• Feldman M, Colturi TJ. Effect of indomethacin on gastric acid and bicarbonate secretion in humans. Gastroenterology 1984; 87: 1339–43
   PubMed Web of Science ®Google Scholar
• Levine R A., Schwartzel EH. Effect of indomethacin on basal and histamine stimulated human gastric acid secretion. Gut 1984; 25: 718–22
   PubMed Web of Science ®Google Scholar
• Main I HM, Whittle B JR. Investigation of the vasodilator and antisecretory role of prostaglandins in the rat gastric mucosa by use of non-steroidal anti-inflammatory drugs. Br J Pharmacol 1975; 53: 217–24
   PubMed Web of Science ®Google Scholar
• Reeves J J., Stables R. Effects of indomethacin, piroxicam and selected prostanoids on gastric acid secretion by the rat isolated gastric mucosa. Br J Pharmacol 1985; 86: 677–84
   PubMed Web of Science ®Google Scholar
• Tabata K, Okabe S. Effects of 16, 16-dimethyl-PGE, -methyl ester on aspirin- and indomethacin-induced gastric and intestinal lesions in mini pigs. Digestion 1983; 26: 61–6
   PubMed Web of Science ®Google Scholar
• Rampton D S., Mc Neil N I., Sarner M. Analgesic ingestion and other factors preceding relapse in ulcerative colitis. Gut 1983; 24: 187–9
   PubMed Web of Science ®Google Scholar
• Ravy S, Keat A C., Keat E CB. Colitis caused by non-steroidal anti-inflammatory drugs. Postgrad Med J 1986; 62: 773–6
   PubMed Web of Science ®Google Scholar
• Schwartz HA. Lower gastrointestinal side effects of non-steroidal antiinflammatory drugs. J Rheum 1981; 8: 952–4
   PubMed Web of Science ®Google Scholar
• Coutrot S, Roland D, Barbier J, Van Der Marcq P, Alacalay M, Matuchansky C. Acute perforation of colonic diverticula associated with short-term indomethacin. Lancet 1978; 2: 1055–6
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Williams P L., So A, Ansell B W., Peters TJ. Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs. Lancet 1984; 2: 1171–5
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Williams P, Smethurst P, Peters T J., Levi AJ. Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine. Gut 1986; 27: 1292–7
   PubMed Web of Science ®Google Scholar
• Pfeiffer CJ. Pathogenesis of ulcer induction revealed by drug studies in humans and animals. In Drugs and peptic ulcer 1982; Vol II: 7–25
   Google Scholar
• Lanza F L., Nelson R S., Royer GL. Effects of ibuprofen, tolmetin and placebo on the gastric mucosa of aspirin-sensitive volunteers. Am J Gastroenterol 1979; 72: 528–34
   PubMed Web of Science ®Google Scholar
• Lanza F L., Royer G L., Nelson R S., Chen T T., Seckman C E., Rack MF. A comparative endoscopic evaluation of the damaging effects of non-steroidal anti-inflammatory agents on the gastric and duodena! mucosa. Am J Gastroenterol 1981; 75: 17–21
   PubMed Web of Science ®Google Scholar
• Lanza FL. Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other non-steroidal anti-inflammatory agents. Am J Med 1984; 77: 19–24
   PubMed Web of Science ®Google Scholar
• Lanza F L., Royer G L., Nelson R S., et al. Effects of flurbiprofen and aspirin on the gastric and duodenal mucosa. Am J Med 1986; 80: 31–5, suppl. 3A
   PubMed Web of Science ®Google Scholar
• Lehtola J, Sipponen P. A gastroscopic and histological double-blind study of the effects of diclofenac sodium and naproxen on the human gastric mucosa. Scand J Rheumatol 1977; 6: 97–102
   PubMed Web of Science ®Google Scholar
• Kurata J H., Elashoff J D., Grossman MI. Inadequacy of the literature on the relationship between drugs, ulcers, and gastrointestinal bleeding. Gastroenterology 1982; 82: 373–82
   PubMed Web of Science ®Google Scholar
• Gibberd FB. Dyspepsia in patients with rheumatoid arthritis. Acta Rheum Scand 1966; 12: 112–21
   PubMedGoogle Scholar
• Sun D C., Roth S H., Mitchell C S., Englund D WW. Upper gastrointestinal disease in rheumatoid arthritis. Dig Dis Sci 1974; 19: 405–10
   Google Scholar
• Smith M D., Gibson R A., Brooks P. Abnormal bowel permeability in ankylosing spondylitis and rheumatoid arthritis. J Rheum 1985; 12: 299–305
   PubMed Web of Science ®Google Scholar
• Segal A W., Isenberg D A., Hajirousou V, Tolfree S, Clark J, Snaith ML. Preliminary evidence for gut involvement in the pathogenesis of rheumatoid arthritis?. Br J Rheumatol 1986; 25: 162–6
   PubMedGoogle Scholar
• Piper D W., McIntosh J H., Greig M, Shy CM. Environmental factors and chronic gastric ulcer. A case control study of the association of smoking, alcohol, and heavy analgesic ingestion with the exacerbation of chronic gastric ulcer. Scand J Gastroenterol 1982; 17: 721–9
   PubMed Web of Science ®Google Scholar
• Levy M. Aspirin use in patients with major upper gastrointestinal bleeding and peptic-ulcer disease. N Engl J Med 1974; 290: 1158–62
   PubMed Web of Science ®Google Scholar
• McIntosh J H., Byth K, Piper DW. Environmental factors in aetiology of chronic gastric ulcer: a case control study of exposure variables before the first symptoms. Gut 1985; 26: 789–98
   PubMed Web of Science ®Google Scholar
• Duggan J M., Dobson A J., Johnson H, Fahey P. Peptic ulcer and non-steroidal anti-inflammatory agents. Gut 1986; 27: 929–33
   PubMed Web of Science ®Google Scholar
• Piper D W., Greig M, Landecker K D., Shinners J, Waller S, Canalese J. Analgesic intake and chronic gastric ulcer. Acute upper gastrointestinal hemorrhage, personality traits and social class. Proc R Soc Med 1977; 70: 11–15
   PubMedGoogle Scholar
• Piper D W., McIntosh J H., Ariotti D E., Fenton B H., Mac Lennan R. Analgesic ingestion and chronic peptic ulcer. Gastroenterology 1981; 80: 427–32
   PubMed Web of Science ®Google Scholar
• Piper D W., Nasiry J, McIntosh C, Pierce J. Smoking, alcohol, analgesics, and chronic duodenal ulcer. Scand J Gastroenterol 1984; 19: 1015–21
   PubMed Web of Science ®Google Scholar
• Larkai E, Smith J L., Lidsky M L., Graham DY. Prospective evaluation of gastroduodenal mucosa in rheumatic patients. Gastroenterology 1986; 90: 1511, abstract
   Web of Science ®Google Scholar
• Lanza F L., Royer G L., Nelson RS. An endoscopic evaluation of the effects of non-steroidal antiinflammatory drugs on the gastric mucosa. Gastrointes Endosc 1975; 21: 103–5
   PubMed Web of Science ®Google Scholar
• O'Laughlin J C., Silvoso G R., Ivey KJ. Healing of aspirin-associated peptic ulcer disease despite continued salicylate ingestion. Arch Intern Med 1981; 141: 781–3
   PubMedGoogle Scholar
• Gow P J., Stewart JT. The arthritic ulcer: a retrospective study of peptic ulceration in patients with rheumatoid arthritis. NZ Med J 1982; 95: 387–9
   PubMed Web of Science ®Google Scholar
• Caldwell JR. Sucralfate in the relief of gastrointestinal symptoms associated with non-steroidal antiinflammatory drugs. South Med J 1985; 78: 938–40
   PubMed Web of Science ®Google Scholar
• Caldwell J R., Roth S H., Marsh W H., Heller M D., Wu W C., Semble E. Sucralfate (SCR) therapy of nonsteroidal anti-inflammatory drug (NSAID) induced gastritis. Clin Pharmacol Ther 1985; 37: 186, abstract
   Web of Science ®Google Scholar
• Bertschinger P H., Lacher G, Aenishänslin W, et al. Presenting characteristics of patients with duodenal ulcer and outcome of medical treatment. Digestion 1986, in press
   Google Scholar
• Piper D W., Greig M, Coupland G AE, Hobbin E, Shinners J. Factors relevant to the prognosis of chronic gastric ulcer. Gut 1975; 16: 714–8
   PubMed Web of Science ®Google Scholar
• Czarnobilski Z, Bem S, Czarnobilski K, Konturek SJ. Carprofen and the therapy of gastroduodenal ulcerations by ranitidine. Hepatogastroenterol 1985; 32: 20–3
   PubMedGoogle Scholar
• Morgan A G., Mc Adam W AF, Pacoso C. Comparison between enprostil and ranitidine in the treatment of gastric ulceration and subsequent follow-up Interim Report. The Britisch Society of Gastroenterology. Sept, 1985; 18–20, Autumn Meeting
   Google Scholar
• Somerville K, Faulkner G, Langman M. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet 1986; 1: 462–4
   PubMed Web of Science ®Google Scholar
• Eberle V F., Rettenmaier G. Kumulation von Risikofaktoren der gastroduodenalen Blutung: Schmerz-/Rheumamittel, Alkohol und Ulkusanamnese. Z Gastroenterol 1985; 23: 107–14
   PubMedGoogle Scholar
• Collier D STJ, Pain JA. Non-steroidal anti-inflammatory drugs and peptic ulcer perforation. Gut 1985; 26: 359–63
   PubMed Web of Science ®Google Scholar
• Peoples JB. Peptic ulcer disease and the non-steroidal anti-inflammatory drugs. Am J Surg 1985; 51: 358–62
   Google Scholar
• Rainsford KD. An analysis of the gastro-intestinal side effects of non-steroidal anti-inflammatory drugs, with particular reference to comparative studies in man and laboratory species. Rheumatol Int 1982; 2: 1–10
   PubMed Web of Science ®Google Scholar
• Paulus HE. SDA Arthritis Advisory Committee Meeting: Post-marketing surveillance of NSAIDs. Arth Rheum 1985; 28: 1168–9
   PubMed Web of Science ®Google Scholar
• Konturek S J., Piastucki I, Brzozowski T, et al. Role of prostaglandins in the formation of aspirin-induced gastric ulcers. Gastroenterology 1981; 80: 4–9
   PubMed Web of Science ®Google Scholar
• Hawkey C J., Rampton DS. Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease, or treatment?. Gastroenterology 1985; 89: 1162–88
   PubMed Web of Science ®Google Scholar
• Ahlquist D A., Dozois R R., Zinsmeister A R., Malagelada JR. Duodenal prostaglandin synthesis and acid load in health and in duodenal ulcer disease. Gastroenterology 1983; 85: 522–9
   PubMed Web of Science ®Google Scholar
• Lange S, Hench V, Malagelada JR. Drug-induced gastric injury in man is directly related to inhibition of mucosal prostaglandin synthesis. Gastroenterology 1986; 90: 1511, abstract
   Web of Science ®Google Scholar
• Isenberg J I., Hogan D L., Koss M A., Selling JA. Human duodenal mucosal bicarbonate secretion. Gastroenterology 1986; 91: 370–8
   PubMed Web of Science ®Google Scholar
• Cheung LY. Topical effects of 16, 16-dimethyl prostaglandin E2 on gastric blood flow in dogs. Am J Physiol 1980; 238: G514–9
   Google Scholar
• Gerber J G., Nies AS. Canine gastric mucosal vasodilation with prostaglandins and histamine analogs. Dig Dis Sci 1982; 27: 870–4
   PubMed Web of Science ®Google Scholar
• Arvidsson S, Fält K, Haglund U. Acute gastric mucosal ulceration in septic shock. Acta Chir Scand 1984; 150: 541–7
   PubMedGoogle Scholar
• Leung F W., Robert A, Guth PH. Gastric mucosal blood flow in rats after administration of 16, 16-dimethyl prostaglandin E2 at a cytoprotective dose. Gastroenterology 1985; 88: 1948–53
   PubMed Web of Science ®Google Scholar
• Leung F W., Miller J C., Guth PH. Dissociated effects of misoprostol on gastric acid secretion and mucosal blood flow. Dig Dis Sci 1986; 31: 86S–90S
   Web of Science ®Google Scholar
• Mc Queen S, Hutton D, Allen A, Garner A. Gastric and duodenal surface mucus gel thickness in rat: effects of prostaglandins and damaging agents. Am J Physiol 1983; G388–93
   Google Scholar
• Halter F, Reinhart W H., Koelz H R., Meyrat P, Lentze M J., Müller O. 16,16-dimethyl prostaglandin E2 stimulates growth and maturation of rat gastric and small intestinal mucosa. Scand J Gastroenterol 1984; 19: 178–83, suppl.92
   PubMed Web of Science ®Google Scholar
• Johansson C, Kollberg B, Nordemar R, Samuelson K, Bergström S. Protective effect of prostaglandin E2 in the gastrointestinal tract during indomethacin treatment of rheumatic diseases. Gastroenterology 1980; 78: 479–83
   PubMed Web of Science ®Google Scholar
• Hunt J N., Smith J L., Jiang C I., Kessler L. Effect of synthetic prostaglandin E1 analog on aspirin-induced gastric bleeding and secretion. Dig Dis Sci 1983; 28: 897–2
   PubMed Web of Science ®Google Scholar
• Hunt J N., Franz DR. Effect of prostaglandin E2 on gastric mucosal bleeding caused by aspirin. Dig Dis Sci 1981; 26: 301–5
   PubMed Web of Science ®Google Scholar
• Yik K Y., Dreidger A A., Watson WC. Prostaglandin E2 tablets prevent aspirin-induced blood loss in man. Dig Dis Sci 1982; 27: 971–5
   Web of Science ®Google Scholar
• Carmichael H A., Nelson L, Russel R I., Chandra V, Lyon A, Cochran KM. Effect of prostaglandin 15(R) 15 methyl-E2 methyl ester on aspirin and taurocholic acid-induced gastric mucosal haemorrhage in rats. Gut 1976; 17: 33–6
   PubMed Web of Science ®Google Scholar
• Cohen M M., Cheung G, Lyster DM. Prevention of aspirin-induced faecal blood loss by prostaglandin E2. Gut 1980; 21: 602–6
   PubMed Web of Science ®Google Scholar
• Terano A, Mach T, Stachura J, Tarnawski A, Ivey KJ. Effect of 16, 16 dimethyl prostaglandin E2 on aspirin induced damage to rat gastric epithelial cells in tissue culture. Gut 1984; 25: 19–25
   PubMed Web of Science ®Google Scholar
• Tarnawski A, Brzozowski T, Sarfeh I J., et al. Protection of isolated human gastric glands by prostaglandin. Fact or fiction? Gastroenterology 1986; 90: 1658, abstract
   Web of Science ®Google Scholar
• v Kolfschoten AA, Hagelen F, Hillen FC, Jager LP, Zandberg P, v. Noordwijk J. Protective effects of prostaglandins against ulcerogenic activity of indomethacin during different stages of erosion development in rat stomach. Dig Dis Sci 1983; 28: 1127–32
   PubMed Web of Science ®Google Scholar
• Sticl D, Ellard K T., Hills U, Brooks PM. Protective effect of enprostil against aspirin-induced gastro-duodenal mucosal injury in man: comparison with cimetidinc and sucralfate. Am J Med 1986; 81: 54–8, suppl. 2A
   PubMed Web of Science ®Google Scholar
• Hawkey C J., Simpson G, Somerville KW. Reduction by enprostil of aspirin-induced blood loss from human gastric mucosa. Am J Med 1986; 81: 50–3, suppl. 2A
   PubMed Web of Science ®Google Scholar
• Silverstein F E., Kimmey M B., Saunders D R., Levine DS. Gastric protection by misoprostol against 1300 mg of aspirin: an endoscopic study. Dig Dis Sci 1986; 31: 137S–141S, suppl. 2
   Web of Science ®Google Scholar
• Cohen M M., Mc Cready D R., Clark L, Sevelius H. Protection against aspirin-induced antral and duodenal damage with enprostil. Gastroenterology 1985; 88: 382–6
   PubMed Web of Science ®Google Scholar
• Cohen MM. Prevention of aspirin-induced fecal blood loss with oral prostaglandin E2: doseresponse studies in man. Prostaglandins 1981; 21: 155–60, suppl
   PubMed Web of Science ®Google Scholar
• Cohen M M., Clark L, Armstrong L, D'Souza A, D'Souza J. Reduction of aspirin induced fecal blood loss with low-dose misoprostol tablets in man. Dig Dis Sci 1985; 30: 605–11
   PubMed Web of Science ®Google Scholar
• Kollberg B, Nordemar R, Johansson C. Gastrointestinal protection by low-dose oral prostaglandin E2 in rheumatic diseases. Scand J Gastroenterol 1981; 16: 1005–8
   PubMed Web of Science ®Google Scholar
• Dammann H G., Simon-Schultz J, Walter ThA, Jenzerski H, Müller P, Simon B. Nocloprost, ein neues PGE2-Analogon: signifikante Reduktion aspirininduzierter Magenschleimhautläsioncn bcim Menschen. Z Gastroenterol 1986; 24: 530, abstract
   Google Scholar
• Dammann H G., Huttemann W, Kalek H D., Rohner G H., Simon B. Comparative clinical trial of enprostil and ranitidine in the treatment of gastric ulcer. Am J Med 1986; 81: 80–4
   PubMed Web of Science ®Google Scholar
• Dammann H G., Walter ThA, Müller P, Simon B. Rioprostil 600 μg nocte: high duodenal ulcer healing rates, low incidence of side effects. Gastroenterology 1986; 90: 1386, abstract
   Web of Science ®Google Scholar
• Koelz H R., Fischer J A., Sachs G, Blum AL. Specific effect of acetylsalicylic acid on cation transport of isolated gastric mucosal cells. AmJPhysiol 1978; 235: E16–21
   Google Scholar
• Cheung LY. Effect of topical 16, 16-dimethyl prostaglandin E2 on aspirin-induced disruption of gastric permeability barrier in dogs. Prostaglandins 1981; 21: 125–9, suppl
   PubMedGoogle Scholar
• Simon B, Dammann H G., Müller P. Gastroduodenal tolerability of nonsteroidal antiinflammatory agents (NOSAC) in man: endoscopic comparative studies with antiulcer drugs. Gastroenterology 1986; 90: 1635, abstract
   Web of Science ®Google Scholar
• Guth P H., Paulsen G, Hirabayashi K. Prostaglandin cytoprotection: prostaglandin does not protect against aspirin- or alcohol-induced red blood cell hemolysis. Dig Dis Sci 1983; 28: 903–7
   PubMed Web of Science ®Google Scholar
• Mac Laurin B P., Watts C, Palmer DG. Protection by sucralfate against indomethacin induced gastric ulceration in the guinea pig. Pathology 1985; 17: 408–11
   PubMed Web of Science ®Google Scholar
• Tesler M A., Lim ES. Protection of gastric mucosa by sucralfate from aspirin-induced erosions. J Clin Gastroenterol 1981; 3: 175–9, suppl. 2
   PubMed Web of Science ®Google Scholar
• Stern A I., Ward F, Hartley G. Sucralfate protects the human stomach from the damaging effects of aspirin. Gastroenterology 1986; 90: 1648, abstract
   Web of Science ®Google Scholar
• Goldenberg M M., Honkomp L J., Burrous S E., Castellion AW. Protective effect of pepto-bismol liquid on the gastric mucosa of rats. Gastroenterology 1975; 69: 636–40
   PubMed Web of Science ®Google Scholar
• Toson G, Bossoni G, Lumachi B. Effects of ranitidine on gastric lesions and antiinflammatory actions of aspirin and indomethacin in the rat. Curr Ther Res 1985; 38: 855–62
   Web of Science ®Google Scholar
• Welch R W., Bentch H L., Harris SC. Reduction of aspirin-induced gastrointestinal bleeding with cimetidine. Gastroenterology 1978; 74: 459–63
   PubMed Web of Science ®Google Scholar
• Guth P H., Aures D, Paulsen G. Topical aspirin plus HC1 gastric lesions in the rat: cytoprotective effect of prostaglandin, cimetidine and probanthine. Gastroenterology 1979; 76: 88–93
   PubMed Web of Science ®Google Scholar
• Nylander O, Berglindh T, Obrink KJ. Prostaglandin interaction with histamine release and parietal cell activity in isolated gastric glands. Am J Physiol 1986; 250: G607–16
   Google Scholar
• Koch K L., Jeffries D, Jeffries GH. Dose-response effects of indomethacin and PGE2 on electromechanical activity of in vivo rabbit ileum. Am J Physiol 1986; 250: G135–9
   Google Scholar
• Svanes K, Critchlow J, Takeuchi K, Magee D, Ito S, Silen W. Factors influencing reconstitution of frog gastric mucosa: role of prostaglandins. Mechanisms of gastric mucosal protection in the upper gastro-intestinal tract., A Allen, G Flenström, A Garner, W Silen, LA. Turnberg. Raven Press, New York 1984; 33–40
   Google Scholar
• Hawkey C J., Walt RP. Prostaglandins for peptic ulcer: a promise unfulfilled. Lancet 1986; 2: 1084–6
   PubMed Web of Science ®Google Scholar
• Aenishänslin W, Bärlocher C, Bernoulli R, et al. Misoprostol und Cimetidin bei der Behandlung des Ulcus duodeni. Schweiz Med Wochenschr 1985; 115: 1225–31
   PubMedGoogle Scholar
• Fich A, Goldin E, Zimmerman J, Ligumski M, Rachmilewitz D. Comparison of misoprostol and cimetidine in the treatment of duodenal ulcer. Isr J Med Sci 1985; 21: 102–6
   PubMedGoogle Scholar
• O'Keefe S JD, Spitals J M., Mannion G, Naiker N. Misoprostol, a synthetic prostaglandin E1 analogue, in the treatment of duodenal ulcers. S Afr Med J 1985; 67: 321–3
   PubMed Web of Science ®Google Scholar
• Bardhan K D., Bose R F., Hinchliffe C, et al. Enprostil (E) versus ranitidine (R) in duodenal ulcer (DU). The British Society of Gastroenterology. Autumn Meeting Sept, 1985; 18–20
   Google Scholar
• Hentschel E, Bounameaux Y, Kratochvil P, Koch H, Ottenjann RV., Ongevalle P. Behandlung des Ulcus duodeni mit Trimoprostil oder Cimetidin. Z Gastroenterol 1985; 23: 445
   Google Scholar
• Vantrappen G, Janssens J, Popiela T, et al. Effect of 15(R)-15-methyl prostaglandin E2 (arbaprostil) on the healing of duodenal ulcers. Gastroenterology 1982; 83: 357–63
   PubMed Web of Science ®Google Scholar
• Bardhan K D., Whittaker L, Hinchcliffe R G., Cleur K, Bose K. Trimoprostil vs cimetidine in duodenal ulcer. Gut 1984; 25: A580
   Web of Science ®Google Scholar
• Brand D L., Roufail W M., Thomson A BR, Tapper EJ. Misoprostol, a synthetic PGE1 analog, in the treatment of duodenal ulcers. A multicenter double-blind study. Dig Dis Sci 1985; 30: 147S–158S
   PubMed Web of Science ®Google Scholar
• Sontag S J., Mazure P A., Pontes J F., Beker S G., Dajani EZ. Misoprostol in the treatment of duodenal ulcer. A multicenter double-blind placebo-controlled study. Dig Dis Sci 1985; 30: 159S–163S
   Web of Science ®Google Scholar
• Agrawal N M., Saffouri B, Kruss D M., Callison D A., Dajani EZ. Healing of benign gastric ulcer. A placebo-controlled comparison of two dosage regimens of misoprostol, a synthetic analog of prostaglandin E, Dig Dis Sci 1985; 30: 164S–170S
   Google Scholar
• Nicholson PA. A multicenter international controlled comparison of two dosage regimes of misoprostol and cimetidine in the treatment of duodenal ulcer in out-patients. Dig Dis Sci 1985; 30: 171S–177S
   PubMed Web of Science ®Google Scholar
• Bright-Asare P, Sontag S J., Gould R J., et al. Efficacy of misoprostol (twice daily dosage) in acute healing of duodenal ulcer. A multicenter double-blind controlled trial. Dig Dis Sci 1986; 31: 63S–67S, suppl. 2
   Web of Science ®Google Scholar
• Rachmilewitz D, Chapman J W., Nicholson PA. A multi-center international controlled comparison of two dosage regimens of misoprostol with cimetidine in treatment of gastric ulcer in outpatients. Dig Dis Sci 1986; 31: 75S–80S
   Web of Science ®Google Scholar
• Thompson A BR, Navert H, Halvorsen L, et al. Treatment of duodenal ulcer with enprostil, a synthetic prostaglandin E2 analogue. Am J Med 1986; 81: 59–63
   Web of Science ®Google Scholar
• Bright-Asare P, Krejs Guenter J, Santangelo W C., et al. Treatment of duodenal ulcer with enprostil, a prostaglandin E2 analogue. Am J Med 1986; 81: 64–8
   PubMed Web of Science ®Google Scholar
• Rampal P, Raillat A, Slama J L., et al. Duodenal ulcer healing. Rioprostil versus ranitidine. Gastroenterology 1986; 90: 1597, abstract
   Web of Science ®Google Scholar
• Winters L, Willcocx R, Ligny G, et al. Comparison of enprostil and cimetidine in active duodenal ulcer disease: summary of pooled European studies. Am J Med 1986; 81: 69–74
   PubMed Web of Science ®Google Scholar
• Walt R P., Long R G., Logan R FA, Somerville K W., Langman M JS, Hawkey CJ. Double-blind clinical trial comparing nocte enprostil with ranitidine in duodenal ulcer. Gastroenterology 1986; 90: 1683, abstract
   Web of Science ®Google Scholar
• Lauritsen K, Lauritsen L S., Havelund T, Bytzer P, Svendsen L B., Rask-Madsen J. Enprostil and ranitidine in duodenal ulcer healing: double blind comparative trial. Br Med J 1986; 292: 864–6
   PubMed Web of Science ®Google Scholar
• Herting R L., Clay GA. Overview of clinical safety with misoprostol. Dig Dis Sci 1985; 30: 185S–193S, suppl. 11
   Web of Science ®Google Scholar
• Lam S K., Lau W Y., Choi T K., et al. Prostaglandin E1 (misoprostol) overcomes the adverse effect of chronic cigarette smoking on duodenal ulcer healing. Dig Dis Sci 1986; 31: 68S–74S
   Web of Science ®Google Scholar
• Simmons T C., Weinstein W M., Shapira M, Grossman MI. A therapeutic trial of 15(R)-methyl prostaglandin E2 in rheumatoid arthritis patients with gastroduodenal lesions. Prostaglandins 1981; 21: 165–73, suppl
   PubMedGoogle Scholar
• Wu W C., Semble E L., Castell D O., et al. Chronic sucralfate therapy of nonsteroidal anti-inflammatory drug-induced gastritis: a multi-center trial. Gastroenterology 1986; 90: 1696
   Web of Science ®Google Scholar
• Levine B A., Sirinek K R., Gaskill HV. Topical prostaglandin E2 in the treatment of acute upper gastrointestinal tract hemorrhage. Arch Surg 1985; 120: 600–4
   PubMedGoogle Scholar
• Fedeli G, Anti M, Rapaccini G L., De Vitis I, Butti A, Civello IM. A controlled study comparing cimetidine treatment to an intensive antacid regimen in the therapy of uncomplicated duodenal ulcer. Dig Dis Sci 1979; 24: 758–62
   PubMed Web of Science ®Google Scholar
• Lauritsen K, Bytzer P, Hansen J, Bekker C, Rask-Madsen J. Comparison of ranitidine and high-dose antacid in the treatment of prepyloric or duodenal ulcer. Scand J Gastroenterol 1985; 20: 123–8
   PubMed Web of Science ®Google Scholar
• Lee F I., Samloff I M., Hardman M. Comparison of tripotassium di-citrato bismuthate tablets with ranitidine in healing and relapse of duodenal ulcers. Lancet 1985; 1: 1299–301
   PubMed Web of Science ®Google Scholar
• Ward M, Halliday C, Cowen AE. A comparison of colloidal bismuth subcitrate tablets and ranitidine in the treatment of chronic duodenal ulcers. Digestion 1986; 34: 173–7
   PubMed Web of Science ®Google Scholar
• Walan A, Jönsson K A., Haglund U, et al. A multicentre double-blind trial of an antacid 4 times daily and cimetidine twice daily on duodenal and prepyloric ulcers. Scand J Gastroenterol 1984; 19: 49, suppl. 98
   Web of Science ®Google Scholar
• Bianchi-Porro G, Parente F, Lazzaroni M, Pace F. Colloidal bismuth subcitrate and two different dosages of cimetidine in the treatment of resistant duodenal ulcer. Scand J Gastroenterol 1986; 21: 39–41, suppl. 122
   Web of Science ®Google Scholar
• Pace F, Bröker H J., Caspary W, et al. Therapie des Ulcus ventriculi mit niedrig dosiertem Antacidumgel und Cimetidin. Dtsch Med Wschr 1985; 110: 283–7
   PubMed Web of Science ®Google Scholar
• Tytgat G NJ, Van Bentem N, Van Olffen G, Dekker W, Rutgeerts L, De Boer J. Controlled trial comparing colloidal bismuth subcitrate tablets, cimetidine and placebo in the treatment of gastric ulceration. Scand J Gastroenterol 1982; 17: 31–8, suppl. 80
   Web of Science ®Google Scholar
• Parente F, Lazzaroni M, Petrillo M, Bianchi-Porro G. Colloidal bismuth subcitrate and ranitidine in the short-term treatment of benign gastric ulcer. Scand J Gastroenterol 1986; 21: 42–5, suppl. 122
   Web of Science ®Google Scholar
• Carlsson C, Jansson L. Bleeding gastric mucosal lesions in intensive care units. Scand J Gastroenterol 1984; 19: 7–8, suppl. 105
   Web of Science ®Google Scholar
• Bresalier R S., Grendell J H., Meyer A A., Cello JP. Sucralfate suspension vs antacids for the prophylaxis of stress-related bleeding in critically ill patients. Gastroenterology 1985; 88: 1334, abstract
   Web of Science ®Google Scholar
• Priebe H J., Skillman J J., Bushnell L S., Long P C., Silen W. Antacids versus cimetidine in preventing acute gastrointestinal bleeding. N Engl J Med 1980; 302: 426–30
   PubMed Web of Science ®Google Scholar
• Hastings P R., Skillman J J., Bushnell L S., Silen W. Antacid titration in the prevention of acute gastrointestinal bleeding. N Engl J Med 1978; 298: 1041–5
   PubMed Web of Science ®Google Scholar
• Zinner M J., Zuidema G D., Smith P, Mignosa M. The prevention of upper gastrointestinal tract bleeding in patients in an intensive care unit. Surg Gynecol Obstet 1981; 153: 214–20
   PubMedGoogle Scholar
• Basso N, Bagarani M, Materia A, Florani S, Lunardi P, Speranza V. Cimetidine and antacid prophylaxis of acute upper gastrointestinal bleeding in high risk patients. Am J Surg 1981; 141: 339–41
   PubMed Web of Science ®Google Scholar
• Bright-Asare P, Giannikopoulos I, Blackstone M, et al. Double-blind controlled pilot trial of misoprostol (Cytotec) compared with antacids in subjects with acute UGI bleeding. Gastroenterology 1986; 90: 1357, abstract
   Web of Science ®Google Scholar
• Hagel J, Lux G, Kaduk B, Ruppin H, Domschke W. Phospholipid compounds and aluminium hydroxide containing antacids protect rat gastric mucosa against ethanol and increase mucosal PGE2 concentrations. Gastroenterology 1985; 88: 1409, abstract
   Web of Science ®Google Scholar
• Quadros E, Johnson J V., Wilson DE. Antacids stimulate prostaglandin (PG) release from gastric mucosa. Gastroenterology 1986; 90: 1595, abstract
   Web of Science ®Google Scholar
• Tarnawski A, Hollander D, Gergely H, Stachura J. Comparison of antacid, sucralfate, cimetidine, and ranitidine in protection of the gastric mucosa against ethanol injury. Am J Med 1985; 79: 19–23, suppl. 2C
   PubMed Web of Science ®Google Scholar
• Hollander D, Tarnawski A, Cummings D, Krause W J., Gergely H, Zipser RD. Cytoprotective action of antacids against alcohol induced gastric mucosal injury. Morphologic, ultrastructural and functional time sequence analysis. Gastroenterology 1984; 86: 1114, abstract
   Web of Science ®Google Scholar
• Szelenyi I, Postius S. Functional cytoprotection by certain antacids and sucralfate in the rat stomach. Gastroenterology 1985; 88: 1604, abstract
   Web of Science ®Google Scholar
• Ch Florent, Flourie B, Bernier JJ. Comparison in man of sucralfate, aluminium phosphate and antacids in protection of gastric mucosa against aspirin. Gastroenterology 1984; 86: 1078, abstract
   Google Scholar
• Hagel J, Wild H, Kachel G, Ruppin H, Domschke W. Adaptation of gastric mucosa to chronic acetylsalicylic acid and cytoprotection by antacid pretreatment. Gastroenterology 1984; 86: 1104, abstract
   Web of Science ®Google Scholar